1.Beugnet, F. and Moreau, Y. 2015. Babesiosis. Rev. Sci. Tech., 34: 627–639.

2.Bourdeau, P. and Guelfi, J.F. 1995. La babésiose canine à Babesia canis, Point Vet., 27: 11–24.

3.Eichenberger, R.M., Riond, B., Willi, B., Hofmann-Lehmann, R. and Deplazes, P. 2016. Prognostic markers in acute Babesia canis infections. J. Vet. Intern. Med., 30: 174–182.

4.Feldman, B.F., Thomason, K.J. and Jain, N.C. 1988. Quantitative platelet disorders. Vet. Clin. N. Am., 8(1): 35–49.

5.Foldvari, G., Hell, E. and Farkas, R. 2005. Babesia canis canis in dogs from Hungary: detection by PCR and sequencing. Vet. Parasitol., 127: 221–226.

6.Harrus, S., Waner, T., Bark, H., Jongejan, F. and Cornelissen, A.W. 1999. Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis. J. Clin. Microbiol., 37: 2745–2749

7.Irwin, P.J. 2009. Canine babesiosis from molecular taxonomy to control. Parasit. Vectors., 2(1): 4-5.

8.Jacobson, L.S. 2006. The South African form of severe and complicated canine babesiosis: clinical advances 1994–2004. Vet. Parasitol., 138: 126–139

9.Kledmanee, K., Suwanpakdee, S., Krajangwong, S. and Chatsiriwech, J. 2009. Development of multiplex polymerase chain reaction for detection of Ehrlichia canis, Babesia spp and hepatozoon canis in canine blood. Se. Asian J. Trop. Med., 40(1): 35-9.

10.Lane, A.E., Chan, M.J. and Wyatt, K.M. 2012. Use of recombinant human granulocyte colonystimulating factor prior to autologous bone marrow transplantation in dogs with lymphoma. Am. J. Vet. Res., 73: 894–899.

11.Leisewitz, A.L., Jacobson, L.S., De Morais, H.S. and Reyers, F. 2001. The mixed acid-base disturbances of severe canine babesiosis. J. Vet. Intern. Med., 15: 445–452.

12.Lin, M.Y. and Huang, H.P. 2010. Use of doxycycline– enrofloxacin– metronidazole combination with and without injections of diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni. Acta. Vet. Scand., 52: 27-28.

13.Lobetti, R.G. 2000. Canine babesiosis. In: M.J. Day, A. Mackin and J.D. Littlewood, BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine, BSAVA, Gloucester., 85–91.

14.Lobetti, R.G. and Jacobson, L.S. 2001. Renal involvement in dogs with babesiosis. J. S. Afr. Vet. Assoc., 72(1): 23–28.

15.Lobetti, R. 2011. Changes in the serum urea: creatinine ratio in dogs with babesiosis, haemolytic anaemia, and experimental haemoglobinaemia. Vet. J., 191: 253–256.

16.Novotny, J., Zvarova, M., Prazakova, L., Jandlova, M. and Konvickova. L. 1995. GCSF in the treatment of patients with chronic aplastic anemia with severe neutropenia, Vnitr. Lek., 41(10): 692-5.

17.Palacios, M., Arteaga, R. and Gustavo, C. 2017. High-dose filgrastim treatment of nonregenerative pancytopenia associated with chronic canine ehrlichiosis. Topics. In. Compan. An. Med., 32: 28–30.

18.Ruiz de Gopegui, R., Penalba, B. and Goicoa, A. 2007. Clinicopathological findings and coagulation disorders in 45 cases of canine babesiosis in Spain. Vet. J., 174: 129–132.

19.Solano Gallego, L. and Baneth, G. 2011. Babesiosis in dogs and cats – expanding parasitological and clinical spectra. Vet. Parasitol, 181: 48–60.

20.Suzuki, K., Wakabayashi, H., Takahashi, M., Fukushima, K., Yabuki, A. and Endo, Y.A. 2007. Possible treatment strategy and clinical factors to estimate the treatment response in Bebesia gibsoni infection. J. Vet. Med. Sci., 69(5): 563-8

21.Vercammen, F., De Deken, R. and Maes, L. 1997. Haematological and biochemical profile in experimental canine ‘babesiosis’ (Babesia canis), Vlaams Diergences- kundig Tijdschrift., 66: 174–178.

22.Wardrop, K.J., Birkenheuer, A., Blais, M.C., Callan, M.B., Kohn, B., Lappin, M.R. and Sykes, J. 2016. Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens. J. Vet. Intern. Med., 30: 15–35.

23.Zygner, W., Gojska Zygner, O. and Norbury, L.J. 2012. Increased AST/ALT ratio in azotaemic dogs infected with Babesia canis. Pol. J. Vet. Sci., 15: 483–486.